Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Literature
1.
Bain BJ (ed) (2006) Haemoglobinopathy diagnosis, 2nd edn. Wiley, London
2.
Okawa T, Tsunekawa S, Seino Y, Hamada Y, Oiso Y (2013) Deceptive HbA1c in a patient with pure red cell aplasia. Lancet 382:366CrossRef
3.
Sharma P, Das R (2016) Cation-exchange high-performance liquid chromatography for variant hemoglobins and HbF/A2: What must hematopathologists know about methodology? World J Methodol 6:20–24CrossRef
4.
Joutovsky A, Hadzi-Nesic J, Nardi MA (2004) HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60,000 samples in a clinical diagnostic laboratory. Clin Chem 50:1736–1747CrossRef
5.
Sacks DB, Arnold M, Bakris GL et al (2011) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 57:e1–e47CrossRef
6.
Little RR et al (2008) Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods. Clin Chem 54:1277–1282CrossRef
7.
Lorenzo-Medina M, De-La-Iglesia S, Ropero P, Nogueira-Salgueiro P, Santana-Benitez J (2014) Effects of hemoglobin variants on hemoglobin A1c values measured using a high-performance liquid chromatography method. J Diabetes Sci Technol 8(6):1168–1176CrossRef
Metadata
Title
CE-HPLC Derived P2 and P3-Peaks in Health and in Hb D-Punjab and HbE States
Authors
Pooja Murgai
Sanjeev Chhabra
Reena Das
Prashant Sharma
Publication date
01-07-2021
Publisher
Springer India
Keyword
Thalassemia
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2021
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01363-z

Other articles of this Issue 3/2021

Indian Journal of Hematology and Blood Transfusion 3/2021 Go to the issue

Short Communication

An Easy Multiplex PCR-SSP Assay for the Genotyping of KEL1 and KEL2 in Multi-transfused Patients

Original Article

Proportion of CD34+CD38−CD123+ Leukemia Stem Cells at Diagnosis Varies in ELN Risk Groups and an Emerging Novel Marker for Prognosticating the Intermediate Risk patients of Acute Myeloid Leukemia: A Prospective Study

Original Article

Prognostic Significance and Prevalence of IgG Subtypes in Rh Haemolytic Disease of Fetus and Newborn

Images

Chromosome 7q31 Amplification in Fluorescence In-Situ Hybridization: A Hallmark of Hepatosplenic Gamma Delta T Cell Lymphoma

Short Communication

Does Mesenchymal Stromal Cell Count in Pre-autologous Hematopoietic Stem Cell Transplant Peripheral Blood and Apheresis Product Predict for Infectious Complications in the Post-transplant Period?

Correspondence

Development of Acquired Hemophilia A After Treatment of Bronchial Asthma with Benralizumab
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits